Xenetic Biosciences Inc. (XBIO) stock surged 24.21% in Monday’s pre-market as of this writing. In the regular trading session on Friday, XBIO’s stock gained 35.48%.
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
Xenetic Biosciences, Inc. (NASDAQ: XBIO) plummeted in the early morning trading session following, a biopharmaceutical corporation focused on the development of XCARTTM, a customized CAR
It is evident with so many people focused on COVID-19 that biotech stocks with coronavirus vaccines and treatments have gained a lot of attention. The
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.